Abstract:AIM: To construct a novel hybrid artificial liver support system (HALSS) and to evaluate its efficacy in patients with severe liver failure.METHODS: Hepatocytes were isolated from suckling pig by the modified Seglen's method. Isolated hepatocytes were cultured in a spinner flask for 24 h to form spheroids before use and the functions of spheroids were detected. HALSS consisted of a plasma separator, a hemo-adsorba and a bioreactor with hepatocytes spheroids in its extra-fiber space. HALSS was applied to 10 patients with severe liver failure. The general condition and the biochemical indexes of the patients were studied just before and after the treatment.RESULTS: The number of cells per liver was about 2-4x10(10) (mean, 3.1 +/- 1.5x10(10)). The cell viabilities were more than 95%. After 24 h of spheroid culture, most hepatocytes formed spheroids. The levels of albumin and urea in the medium of spheroid culture were higher than those in supernatant of petri dish culture (P = 0.0015 and 0.0001, respectively). The capacity of albumin production and urea synthesis remained stable for more than one wk and declined rapidly after two weeks in vitro. In HALSS group, the duration of HALSS treatment was 6-10 h each time. All patients tolerated the treatment well without any fatal adverse reaction. After HALSS treatment, the general condition, psychic state, encephalopathy and hepatic function of the patients were improved. The survival rate of the HALSS group, Plasmapheresis group and control group was 30% (3/10), 20% (2/10) and 0% (0/10), respectively (P = 0.024). Two weeks after treatment, Tbil and ALT decreased and the PTA level elevated in HALSS group and pasmapheresis group (P value: 0.015 vs 0.020, 0.009 vs 0.012 and 0.032 vs 0.041, respectively). But there was no significant change of blood albumin concentration before and after treatment in HALSS group and Plasmapheresis group.CONCLUSION: The HALSS established by us is effective in supporting liver function of patients with severe liver failure. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.

Evaluation of a Novel Hybrid Bioartificial Liver Based on Multi-Layer Fiat-Plate Bioreactor

Evaluation of a novel hybrid bioartificial liver based on a multi-layer flat-plate bioreactor.

Primary Clinical Study of a Novel Multi-Layer Flat-Plate Bioartificiai Liver for Patients with Liver Failure

Bioartificial liver system based on choanoid fluidized bed bioreactor improve the survival time of fulminant hepatic failure pigs.

Primary clinical study of a novel bioartificial liver combined with liver transplantation in patients with liver failure

The Development of a New Bioartificial Liver and Its Application in 12 Acute Liver Failure Patients

Efficacy of Fluidized Bed Bioartificial Liver in Treating Fulminant Hepatic Failure in Pigs: A Metabolomics Study

The Clinical Effect of Hybrid Bioartificial Liver on Acute Hepatic Failure with Gravis Hepatitis

Preliminary evaluation on the effects of a hybrid bioartificial liver support system in the treatment of hepatic failure

Advances in cell sources of hepatocytes for bioartificial liver.

A Novel Bioartificial Liver and Its Metabolic Effects on the Serum of Severe Hepatitis

Functional Evaluation of a New Bioartificial Liver System in Vivo and in Vivo

Preliminary Study on a Hybrid Bioartificial Liver Support System in the Treatment of Severe Hepatitis

Experimental study of bioartificial liver with cultured human liver cells.

Improved survival of porcine acute liver failure by a bioartificial liver device implanted with induced human functional hepatocytes

Liver failure and the progress of Li's artificial liver system

A Single-Center Experience of Non-Bioartificial Liver Support Systems among Chinese Patients with Liver Failure

The Efficacy Research of Multi-Layer Flat-Platebioartificial Liver on Acute Liver Failure

Efficacy of Coupled Low-Volume Plasma Exchange with Plasma Filtration Adsorption in Treating Pigs with Acute Liver Failure: A Randomised Study.

Hybrid Artificial Liver Support System for Treatment of Severe Liver Failure

A Clinical Study on the Treatment of Severe Hepatitis by a Combined Artificial Liver.